myeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing to Quickly Match Patients with Appropriate Trials Across North America WALTHAM, Mass. -- To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National [...]

Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and treatment strategies. New technology will work to capture and analyze the highly heterogeneous tumor microenvironment. WASHINGTON -- Danaher Corporation (NYSE: DHR), a global science and [...]

Eurofins Clinical Enterprise, LLC and SeqMatic first providers to join program, expanding access to Parse’s growing single cell portfolio SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of its Certified Service Provider (CSP) Program. For researchers who are seeking paths to outsource their single [...]

Former Agena Bioscience EVP and GM to lead Mission Bio’s marketing, sales, and customer support efforts SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the appointment of Roman Haehn as Chief Commercial Officer. Drawing on more than 25 years of experience in diagnostics and life sciences [...]

Nijmegen, Netherlands - MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with Predica Diagnostics, a leading innovator in oncology diagnostics, to develop Predica’s targeted RNA sequencing tests on the cost-effective MGI Next-generation [...]

BugSeq, an innovative biotech company that provides a user-friendly and rapid bioinformatics platform for clinical and public health laboratories, announces it has entered a public-private partnership with the Biomedical Advanced Research and Development Authority's (BARDA) Division of Research, Innovation, and Ventures (DRIVe) to develop an artificial intelligence (AI)-powered reporting tool for clinical metagenomics data. BARDA is [...]

Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of [...]

Illumina has signed a research collaboration agreement with the National Cancer Centre Singapore to better diagnose and treat adolescent and young adult (AYA) lymphoma in Asian cohorts, potentially benefiting more than 1000 patients in Singapore per year. As part of the agreement, Illumina will support with its industry-leading genome sequencing platforms, including the NovaSeq™ 6000. [...]

Park Systems, a leading manufacturer of nano-metrology systems, announces the release of its latest atomic force microscopy (AFM) innovation, Park FX200, designed for 200 mm samples. The FX200 is developed to meet the needs of both research and industrial applications, offering significant advancements in large-sample AFM technology. The FX200 features an advanced mechanical structure that [...]

Latest technology advancements also enhance capabilities in core industries, including logistics and energy WATERTOWN, Mass. -- Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire” or the “Company”), a pioneer in environmental measurement technology, today announced the upcoming release of AireCore 2.0, the next generation in micro mass spectrometry. Scheduled for shipment in Q1 2025, AireCore 2.0 will [...]